High Activity of Fosfomycin and Rifampin against Methicillin-Resistant Staphylococcus aureus Biofilm In Vitro and in an Experimental Foreign-Body Infection Model

Increasing antimicrobial resistance reduces treatment options for implant-associated infections caused by methicillin-resistant Staphylococcus aureus (MRSA). We evaluated the activity of fosfomycin alone and in combination with vancomycin, daptomycin, rifampin, and tigecycline against MRSA (ATCC 433...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mihailescu, Raluca, Furustrand Tafin, Ulrika, Corvec, Stéphane, Oliva, Alessandra, Betrisey, Bertrand, Borens, Oliver, Trampuz, Andrej
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2014
Materias:
Experimental Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3993211/
https://ncbi.nlm.nih.gov/pubmed/24550327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02420-12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares